TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

Recruiting

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Adult patients (≥ 18 years) with acute ischemic stroke and atrial fibrillation
- Eligible and willing to start (or re-start) NOAC
- Registered in The Swedish Stroke Register
- Signed informed consent

Exclusion Criteria

- Contraindication to NOAC (e.g. ongoing bleeding, mechanical heart valve prosthesis)
- Ongoing therapy with NOAC (without ≥2 days interruption at index stroke)
- International normalized ratio (INR)>1.7
- No second brain imaging (CT/MRI) after thrombolysis/thrombectomy
- Previous randomization in the TIMING study